DUBLIN--(BUSINESS WIRE)--The "Artificial Tendons and Ligaments Market by Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, Spine Injuries, and Hip Injuries), and Region (North America, Europe, Asia Pacific, Rest of the World) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global artificial tendons and ligaments market is expected to reach USD 35 million by 2023 from USD 18.5 million in 2018, at a CAGR of 13.6%.
Based on application, the market is segmented into knee injuries, shoulder injuries, foot and ankle injuries, and other injuries (spine and hip injuries).
The knee injuries segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing incidence of knee injuries, discomfort at the harvest site due to conventional surgical treatment methods that use autografts and allografts, rising participation in sports, and advantages of artificial tendons and ligaments as compared to autografts and allografts.
- Increasing Incidence of Sports Injuries
- Growing Number of Initiatives to Increase Awareness About Artificial Tendons and Ligaments
- Increasing Research Activities on Artificial Tendons and Ligaments
- Increasing Preference for Minimally Invasive Surgeries
- Benefits of Artificial Tendons and Ligaments
- Issues Related to the Use of Orthobiologics
- Reluctance to Use Artificial Tendons and Ligaments Among Healthcare Providers
- High Procedure Costs and Unfavorable Reimbursement Scenario Across Major Markets
- Expansion and Market Penetration Opportunities in Emerging Economies
- Limited Clinical Evidence to Support the Efficacy of Artificial Tendons and Ligaments
- Lack of Trained Professionals
Key Topics Covered
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Initial Artificial Tendons and Ligaments: Product Failures
7 Industry Speaks
8 Artificial Tendons and Ligaments Market, By Application
9 Artificial Tendons and Ligaments Market, By Region
10 Market Share Analysis
11 Company Profiles
- Neoligaments (a Division of Xiros)
- Cousin Biotech
- FX Solutions
- Shanghai Pine&Power Biotech
For more information about this report visit https://www.researchandmarkets.com/research/8zcgfb/global_35?w=4